Mas de 100 años, desde 1911, cuando Noon y colaboradores iniciaron la Inmunoterapia en Inglaterra. Frankland, uno de los científicos investigadores, está vivo. Hemos usado la Inmunoterapia con exito desde la Universidad de Kansas. USA y en el Centro Medico de Caracas. Venezuela.
Official Topic from UpToDate®, the clinical decision support resource accessed by 700,000+ clinicians worldwide. Available via the web and mobile devices, subscribe to UpToDate® at www.uptodate.com/store.
Author
Mübeccel Akdis, MD, PhD
Mübeccel Akdis, MD, PhD
Section Editor
Peter S Creticos, MD
Peter S Creticos, MD
Deputy Editor
Anna M Feldweg, MD
Anna M Feldweg, MD
All topics are updated as new evidence becomes available and our peer review process is complete.
Literature review current through: May 2016. | This topic last updated: May 31, 2016.
INTRODUCTION — Allergen
immunotherapy (AIT) is the most effective treatment available for
several common allergic diseases. Subcutaneous immunotherapy (SCIT) is
the best studied form of AIT and is effective for allergic rhinitis and
rhinoconjunctivitis, allergic asthma, and Hymenoptera venom allergy.
SCIT involves the repeated subcutaneous injection of increasing amounts
of allergen beginning with very small doses of allergen and gradually
increasing to higher doses. Another popular method of AIT involves oral,
or more specifically, sublingual administration, in the form of
dissolvable tablets or extracts. This topic will discuss the known
immunologic changes that occur during AIT. Other topics related to AIT
are found separately:
No comments:
Post a Comment